LifeScience Cell & Gene
Biocytogen Expands Preclinical Capabilities Across Asia and the U.S. with Over 1,000 Humanized Mouse Models
Biocytogen (HKEX: 02315), an international biotechnology company that drives new drug development with innovative technologies, announced that its pr...
July 29, 2025 | News
Sarepta Therapeutics Reaffirms Commitment to Patient Safety Following FDA Update on Unrelated Fatality
Sarepta Therapeutics, Inc. (NASDAQ: SRPT), the leader in precision genetic medicine for rare diseases, issued the following statement in response to an FDA...
July 28, 2025 | News
10x Genomics and A*STAR GIS Join Forces to Advance Precision Medicine Through AI-Powered Spatial Biology
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, and the A*STAR Genome Institute of Singapore (A*STAR GIS), announced a resea...
July 21, 2025 | News
FDA Pulls Emergency Brake on Sarepta's Gene Therapy Trials Amid Fatal Safety Crisis
The U.S. Food and Drug Administration announced it has placed Sarepta Therapeutics investigational gene therapy clinical trials for limb girdle muscular dy...
July 21, 2025 | Regulatory
Thermo Fisher Scientific Expands Rapid CGP Access with Oncomine™ Comprehensive Assay Plus on Genexus™ System
Thermo Fisher Scientific announced that the Oncomine™ Comprehensive Assay Plus* is now available on the Ion Torrent™ Genexus™ System* hel...
July 15, 2025 | News
Amarna Therapeutics and NorthX Biologics Advance Nimvec™ AM510 Toward Clinical Trials for Type 1 Diabetes
Fast-Tracking Clinical Readiness: The agreement enables process and analytical development activities required to advance Nimvec™ AM510 for Type 1 ...
July 14, 2025 | News
Elegen and Nutcracker Therapeutics Launch Cell-Free Platform Pilot to Transform RNA-Based Personalised Cancer Therapeutics
Elegen, a global leader in next-generation DNA manufacturing, and Nutcracker Therapeutics, a global leader in next-generation RNA design and manufactu...
July 14, 2025 | News
I Peace and Vita Therapeutics Partner to Develop Universal Hypoimmune iPSC Lines for Cell Therapy
Leading GMP cell CDMO I Peace, Inc. specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that the co...
July 11, 2025 | News
Univercells Technologies and Repligen Collaborate to Advance Real-Time Monitoring in Viral Vector and Vaccine Manufacturing
Univercells Technologies, a Donaldson Life Sciences business and global provider of bioprocessing solutions, announced a collaboration with Repli...
July 10, 2025 | News
SCG Cell Therapy Secures China NMPA IND Approval for First Cell Therapy Targeting Chronic Hepatitis B
SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announ...
July 08, 2025 | News
Japanese Life Sciences Delegation Strengthens Collaboration with North Carolina’s Innovation Ecosystem
A high-level Japanese delegation specializing in life sciences concluded a three-day visit to North Carolina (June 24–26), further strengthening ties...
July 07, 2025 | News
AvenCell Secures Up to $40 Million AMED Grant to Advance Dual-Antigen Allogeneic CAR-T Therapy
AvenCell Japan, a wholly owned subsidiary of AvenCell Therapeutics, a private, clinical-stage biotechnology company developing best-in-class CAR-T therapie...
July 02, 2025 | News
HanchorBio Licenses Novel CD47 Fusion Protein HCB101 to Henlius in $200 Million+ Regional Deal
HanchorBio Inc. (7827.TWO), a global clinical-stage biotechnology company developing innovative immunotherapies for oncology and autoimmune diseases, annou...
July 02, 2025 | News
Klotho Neurosciences Advances KLTO-202 Gene Therapy Manufacturing for ALS Clinical Trials
Klotho Neurosciences, Inc. announced that it is moving forward with manufacturing and process development work in preparation for clinical trials of K...
July 01, 2025 | News
Most Read
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
